Margaret Haney, PhD
Professor of Neurobiology (in Psychiatry) at CUMC
Executive Committee, Division on Substance Abuse
Director of the Pilot Project Committee: Substance Use Research Center
Grand Rounds Committee, Department of Psychiatry
Columbia University: Lilly Innovation Fellowship Committee
Dr. Margaret (Meg) Haney is a Professor of Neurobiology (in Psychiatry) at the Columbia University Medical Center, where she is the Director of the Marijuana Research Laboratory and Co-Director of the Substance Use Research Center. Her research focuses on human laboratory models of cannabis and cocaine use disorders and the assessment of novel pharmacologic and immunologic approaches to treat these disorders. Her particular interest is to define the factors that contribute to the daily use of drugs. Her publications to date have largely focused on: (1) the positive and negative reinforcing effects of cocaine and cannabis, (2) the effects of medications on cannabis and cocaine self-administration, (3) predictors of cannabis withdrawal and relapse, (4) the potential medical benefits of cannabinoids, and (5) the role of opioid receptors in mediating cannabis’s subjective-effects.
Dr. Haney's research has been continuously supported by NIDA since 1999. She is internationally recognized for her expertise, particularly regarding cannabis use disorder. She is an author on more than 125 articles in peer-reviewed journals and 11 book chapters, is an Associate Editor for Cannabis and Cannabinoid Research, an advisory editor for Psychopharmacology, a longstanding participant in NIH review groups, and is a member of the American College of Neuropsychopharmacology and the College on Problems of Drug Dependence, where she currently serves on the Board of Directors.